HCA Healthcare (HCA)
(Delayed Data from NYSE)
$403.28 USD
-0.58 (-0.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $403.24 -0.04 (-0.01%) 6:36 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$403.28 USD
-0.58 (-0.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $403.24 -0.04 (-0.01%) 6:36 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Zacks News
New Strong Buy Stocks for August 20th
by Zacks Equity Research
ZIM, HCA, MRX, SN and TWO have been added to the Zacks Rank #1 (Strong Buy) List on August 20, 2024.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
Best Value Stocks to Buy for August 20th
by Zacks Equity Research
ZIM, HCA, and MRX made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 20, 2024.
5 Hospital Stocks Poised to Benefit From Strong Industry Growth
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry will gain from increasing admissions and cybersecurity and technological advancements. Companies like HCA, UHS, THC, ACHC and CYH are poised to gain from these trends.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Here's Why Investors Should Hold Acadia (ACHC) Stock for Now
by Zacks Equity Research
Acadia Healthcare (ACHC) remains well-poised for growth on the back of the solid demand for behavioral healthcare services, continuous pursuit of expansion initiatives and a notable financial position.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
If You Invested $1000 in HCA Healthcare a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Zacks.com featured highlights include HCA Healthcare, Hubbell, Popular and Lennox International
by Zacks Equity Research
HCA Healthcare, Hubbell, Popular and Lennox International are part of the Zacks Screen of the Week article.
4 GARP Stocks to Scoop up for Maximum Returns
by Zacks Equity Research
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, BPOP and LII are some stocks that hold promise.
How to Find Strong Buy Medical Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Pediatrix (MD) Q2 Earnings Top on Stable Volumes, Shares Up 7.4%
by Zacks Equity Research
Pediatrix's (MD) second-quarter earnings benefit from stable patient volumes. Rising expenses act as a partial offset.
Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Athira Pharma, Inc. (ATHA) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
Select Medical's (SEM) Stock Down 16.9% Despite Q2 Earnings Beat
by Zacks Equity Research
Select Medical (SEM) expects its adjusted EBITDA between $845 million and $885 million for 2024, the mid-point of which implies a 7.1% rise from the 2023 reported figure of $807.4 million.
National Fuel Gas and Landstar System Industries have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
National Fuel Gas and Landstar System Industries have been highlighted as Zacks Bull and Bear of the Day
3 Sector ETFs & Stocks to Bet on July Jobs Data
by Sanghamitra Saha
The US economy added 114,000 jobs in July 2024, well below a downwardly revised 179,000 in June and forecasts of 175,000.
Global Week Ahead: Nervous Stock Markets
by John Blank
Earnings season has been pretty solid so far, but that's not enough to calm jittery investors who are concerned about a recession that still appears unlikely. So get ready for another volatile week.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat
by Zacks Equity Research
Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.
Zacks.com featured highlights include HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies
by Zacks Equity Research
HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies are part of the Zacks Screen of the Week article.
ETFs & Stocks in Focus on Kamala Harris' Shift in Strategy
by Sanghamitra Saha
Analysts have noticed that Harris's 2024 campaign for president is a bit different than what it was in 2024, as quoted on yahoo finance.
Cigna (CI) Q2 Earnings Top on Specialty Business Strength
by Zacks Equity Research
Cigna's (CI) Q2 results reflect new client wins in the Evernorth Health Services unit, partly offset by elevated pharmacy costs. It continues to expect adjusted EPS of at least $28.40 for 2024.
5 Top-Ranked Dividend Stocks for Growth of Your Portfolio
by Sweta Killa
HCA Healthcare (HCA), Taiwan Semiconductor (TSM), H&R Block (HRB), Leidos Holdings. (LDOS) and The TJX Companies (TJX) could be solid choices for your portfolio.
Q2 Boost for Tenet (THC): A Healthy Dose of Long-Term Gains
by Kaibalya Pravo Dey
Tenet (THC) shares jump 8.3% since Q2 earnings beat, as investors grow increasingly confident about the company's future prospects.